Concord Drugs (BOM:538965) Net Income Including Noncontrolling Interests : ₹3.4 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Concord Drugs Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Concord Drugs's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was ₹0.4 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was ₹3.4 Mil.

Concord Drugs Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Concord Drugs's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Drugs Net Income Including Noncontrolling Interests Chart

Concord Drugs Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Net Income Including Noncontrolling Interests

Get a 7-Day Free Trial

32.82

15.94

9.86

4.72

3.36

Concord Drugs Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income Including Noncontrolling Interests	Get a 7-Day Free Trial															-3.39	0.27	0.43	2.27	0.39

Concord Drugs Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3.4 Mil.

Concord Drugs Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Concord Drugs's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Concord Drugs Ltd (BOM:538965) » Definitions » Net Income Including Noncontrolling Interests

Traded in Other Exchanges

N/A

Address

Survey No. 249, Brahmanapally Village, Hayatnagar Mandal, Ranga Reddy, Hyderabad, TG, IND, 501511

Website

https://www.concorddrugs.in

Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers.

Concord Drugs Headlines

No Headlines